Alexion Pharmaceuticals, Inc. (ALXN) Social Stream
Warning: This security is no longer trading.
Alexion Pharmaceuticals Inc (ALXN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ALXN.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 14 | $205 | $166 | $177.36 | $179.45 | -1.16% |
The Trend in the Analyst Price Target
ALXN's average price target has moved up $32.98 over the prior 37 weeks.
Over the past 14 months, ALXN's average upside potential has been 12.73%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-07-17 | 14 | 205 | 166 | 177.36 | 180.03 | -1.48% |
| 2021-07-10 | 14 | 205 | 166 | 177.36 | 184.20 | -3.71% |
| 2021-07-03 | 14 | 205 | 166 | 177.36 | 186.28 | -4.79% |
| 2021-06-26 | 14 | 205 | 166 | 177.36 | 182.74 | -2.94% |
| 2021-06-13 | 14 | 205 | 166 | 177.36 | 181.65 | -2.36% |
| 2021-06-05 | 14 | 205 | 166 | 177.36 | 177.12 | 0.14% |
| 2021-05-22 | 14 | 205 | 166 | 177.36 | 177.72 | -0.2% |
| 2021-05-15 | 14 | 205 | 166 | 177.36 | 173.49 | 2.23% |
| 2021-05-08 | 14 | 205 | 166 | 177.36 | 170.43 | 4.07% |
| 2021-04-25 | 14 | 190 | 155 | 172.50 | 166.92 | 3.34% |
| 2021-04-17 | 14 | 190 | 155 | 172.50 | 163.68 | 5.39% |
| 2021-04-10 | 15 | 190 | 155 | 172.00 | 155.01 | 10.96% |
| 2021-04-03 | 15 | 190 | 155 | 172.00 | 153.21 | 12.26% |
| 2021-03-20 | 15 | 196 | 155 | 174.67 | 150.94 | 15.72% |
| 2021-03-13 | 17 | 196 | 140 | 172.65 | 151.59 | 13.89% |
| 2021-03-06 | 17 | 196 | 140 | 172.65 | 150.10 | 15.02% |
| 2021-02-27 | 17 | 196 | 140 | 172.65 | 152.75 | 13.03% |
| 2021-02-20 | 17 | 196 | 140 | 172.65 | 155.51 | 11.02% |
| 2021-02-13 | 17 | 196 | 140 | 172.65 | 158.39 | 9% |
| 2021-02-06 | 17 | 196 | 140 | 172.65 | 153.92 | 12.17% |
| 2021-01-30 | 17 | 200 | 140 | 173.65 | 153.33 | 13.25% |
| 2021-01-23 | 17 | 200 | 140 | 173.65 | 159.73 | 8.71% |
| 2021-01-16 | 17 | 200 | 140 | 173.65 | 156.70 | 10.82% |
| 2021-01-09 | 17 | 200 | 140 | 173.65 | 157.35 | 10.36% |
| 2021-01-02 | 17 | 200 | 125 | 170.71 | 156.24 | 9.26% |
| 2020-12-26 | 17 | 200 | 125 | 170.71 | 152.63 | 11.85% |
| 2020-12-19 | 17 | 200 | 125 | 170.71 | 156.75 | 8.91% |
| 2020-12-09 | 20 | 179 | 119 | 145.35 | 117.74 | 23.45% |
| 2020-12-07 | 20 | 179 | 119 | 145.35 | 118.83 | 22.32% |
| 2020-11-19 | 21 | 179 | 119 | 146.38 | 122.05 | 19.93% |
| 2020-11-07 | 20 | 179 | 119 | 146.05 | 125.26 | 16.6% |
| 2020-10-29 | 21 | 179 | 119 | 144.38 | 118.21 | 22.14% |
| 2020-09-21 | 19 | 175 | 114 | 142.95 | 111.74 | 27.93% |
| 2020-09-17 | 19 | 175 | 114 | 142.95 | 114.13 | 25.25% |
| 2020-08-28 | 18 | 175 | 114 | 143.11 | 106.99 | 33.76% |
| 2020-08-12 | 18 | 175 | 114 | 143.28 | 102.78 | 39.4% |
| 2020-07-30 | 18 | 175 | 114 | 143.28 | 104.81 | 36.7% |
| 2020-07-21 | 19 | 170 | 111 | 139.37 | 107.01 | 30.24% |
| 2020-07-18 | 19 | 170 | 111 | 139.37 | NA | NA% |
| 2020-07-08 | 20 | 170 | 111 | 138.85 | NA | NA% |
| 2020-06-19 | 20 | 170 | 111 | 138.75 | NA | NA% |
| 2020-06-11 | 21 | 170 | 111 | 138.81 | NA | NA% |
| 2020-06-05 | 20 | 170 | 111 | 138.50 | NA | NA% |
ALXN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.88 | 1 | 2 | 13 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
Over the past 150 days, ALXN's average broker recommendation rating worsened by 0.03.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Alexion Pharmaceuticals Inc's average analyst price target is greater than 92.7% of all US stocks.
- ALXN has a greater upside potential (average analyst target price relative to current price) than 6.4% of Pharmaceutical Products stocks.
- Alexion Pharmaceuticals Inc's number of analysts covering the stock is greater than 92.32% of Pharmaceutical Products stocks.
- Alexion Pharmaceuticals Inc's variance in analysts' estimates is lower than 81.75% of stocks in the large market cap category.
Stocks similar to Alexion Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TLRY, PFE and FOLD.
Is ALXN a Buy, Hold or Sell? See the POWR Ratings now!